A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

PHASE2TerminatedINTERVENTIONAL
Enrollment

564

Participants

Timeline

Start Date

May 14, 2007

Primary Completion Date

December 26, 2008

Study Completion Date

December 26, 2008

Conditions
Osteoporosis
Interventions
DRUG

Ronacaleret

100mg, 200mg, 300mg, 400mg

DRUG

Teriparatide

PTH (1-34)

DRUG

Alendronate

Bisphosphonate

Trial Locations (49)

1012

GSK Investigational Site, Buenos Aires

2065

GSK Investigational Site, St Leonards

2196

GSK Investigational Site, Rosebank

2317

GSK Investigational Site, Hamar

2750

GSK Investigational Site, Ballerup Municipality

3011

GSK Investigational Site, Footscray

3081

GSK Investigational Site, Heidelberg

3220

GSK Investigational Site, Geelong

3300

GSK Investigational Site, Tienen

4020

GSK Investigational Site, Liège

5094

GSK Investigational Site, Bergen

7130

GSK Investigational Site, Somerset West

7500

GSK Investigational Site, Panorama

9000

GSK Investigational Site, Ghent

10559

GSK Investigational Site, Berlin

12203

GSK Investigational Site, Berlin

12247

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

14050

GSK Investigational Site, Mexico City

15705

GSK Investigational Site, Santiago de Compostela

15706

GSK Investigational Site, Santiago de Compostela

16635

GSK Investigational Site, Duncansville

20817

GSK Investigational Site, Bethesda

22143

GSK Investigational Site, Hamburg

22415

GSK Investigational Site, Hamburg

28007

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

30033

GSK Investigational Site, Decatur

44195

GSK Investigational Site, Cleveland

44313

GSK Investigational Site, Akron

60528

GSK Investigational Site, Frankfurt am Main

92260

GSK Investigational Site, Palm Desert

94598

GSK Investigational Site, Walnut Creek

94609

GSK Investigational Site, Oakland

97213

GSK Investigational Site, Portland

117292

GSK Investigational Site, Moscow

127299

GSK Investigational Site, Moscow

C1117ABH

GSK Investigational Site, Ciudad Autónoma de Buenos Aires

C1128AAF

GSK Investigational Site, Buenos Aires

Unknown

GSK Investigational Site, Hong Kong

GSK Investigational Site, Shatin

0176

GSK Investigational Site, Oslo

86-300

GSK Investigational Site, Grudziądz

02-341

GSK Investigational Site, Warsaw

50-088

GSK Investigational Site, Wroclaw

120-752

GSK Investigational Site, Seoul

443-721

GSK Investigational Site, Suwon

08003

GSK Investigational Site, Barcelona

08022

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY